175 related articles for article (PubMed ID: 32200011)
1. Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort.
Islim AI; Mohan M; Moon RDC; Rathi N; Kolamunnage-Dona R; Crofton A; Haylock BJ; Mills SJ; Brodbelt AR; Jenkinson MD
World Neurosurg; 2020 Jun; 138():e725-e735. PubMed ID: 32200011
[TBL] [Abstract][Full Text] [Related]
2. Volumetric growth rate of incidental asymptomatic meningiomas: a single-center prospective cohort study.
Delgado-López PD; Montalvo-Afonso A; Martín-Alonso J; Martín-Velasco V; Castilla-Díez JM; Galacho-Harriero AM; Ortega-Cubero S; Sánchez-Rodríguez A; Rodríguez-Salazar A
Acta Neurochir (Wien); 2021 Jun; 163(6):1665-1675. PubMed ID: 33751215
[TBL] [Abstract][Full Text] [Related]
3. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
[TBL] [Abstract][Full Text] [Related]
4. Risk profile associated with convexity meningioma resection in the modern neurosurgical era.
Sanai N; Sughrue ME; Shangari G; Chung K; Berger MS; McDermott MW
J Neurosurg; 2010 May; 112(5):913-9. PubMed ID: 19645533
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
7. Is Fractionated Gamma Knife Radiosurgery a Safe and Effective Treatment Approach for Large-Volume (>10 cm
Han MS; Jang WY; Moon KS; Lim SH; Kim IY; Jung TY; Jung S
World Neurosurg; 2017 Mar; 99():477-483. PubMed ID: 28017757
[TBL] [Abstract][Full Text] [Related]
8. [Strategy for the treatment of incidental meningiomas].
Nabika S; Kiya K; Satoh H; Mizoue T; Oshita J; Kondo H
No Shinkei Geka; 2007 Jan; 35(1):27-32. PubMed ID: 17228765
[TBL] [Abstract][Full Text] [Related]
9. A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas.
Islim AI; Kolamunnage-Dona R; Mohan M; Moon RDC; Crofton A; Haylock BJ; Rathi N; Brodbelt AR; Mills SJ; Jenkinson MD
Neuro Oncol; 2020 Feb; 22(2):278-289. PubMed ID: 31603516
[TBL] [Abstract][Full Text] [Related]
10. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation.
Cohen-Inbar O; Tata A; Moosa S; Lee CC; Sheehan JP
J Neurosurg; 2018 Feb; 128(2):362-372. PubMed ID: 28338439
[TBL] [Abstract][Full Text] [Related]
12. [Factors contributing to recurrence of intracranial meningiomas and indications to postoperative radiotherapy].
Zukiel R; Liebert W; Jankowski R; Nowak S; Szymaś J; Pawlak Z; Tokarz F
Neurol Neurochir Pol; 1994; 28(3):343-50. PubMed ID: 8084365
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy.
Press RH; Prabhu RS; Appin CL; Brat DJ; Shu HK; Hadjipanayis C; Olson JJ; Oyesiku NM; Curran WJ; Crocker I
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1004-10. PubMed ID: 24661652
[TBL] [Abstract][Full Text] [Related]
14. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.
Jääskeläinen J; Haltia M; Servo A
Surg Neurol; 1986 Mar; 25(3):233-42. PubMed ID: 3945904
[TBL] [Abstract][Full Text] [Related]
15. Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes.
Islim AI; Mohan M; Moon RDC; Srikandarajah N; Mills SJ; Brodbelt AR; Jenkinson MD
J Neurooncol; 2019 Apr; 142(2):211-221. PubMed ID: 30656531
[TBL] [Abstract][Full Text] [Related]
16. [Operability of intracranial meningiomas].
Philippon J
Bull Acad Natl Med; 2003; 187(3):591-8; discussion 598-600. PubMed ID: 14556472
[TBL] [Abstract][Full Text] [Related]
17. Matched case-control analysis of outcomes following surgical resection of incidental meningioma.
Chotai S; Tang AR; Gupta R; Guidry BS; McDermott JR; Grisham CJ; Morone PJ; Thompson RC; Chambless LB
J Neurooncol; 2022 Nov; 160(2):481-489. PubMed ID: 36326943
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.
D'Amico RS; Banu MA; Petridis P; Bercow AS; Malone H; Praver M; Wang TJC; Isaacson SR; Sisti MB
J Neurosurg; 2017 Dec; 127(6):1231-1241. PubMed ID: 28186449
[TBL] [Abstract][Full Text] [Related]
19. Gamma Knife radiosurgery for intracranial benign meningiomas: follow-up outcome in 130 patients.
Ge Y; Liu D; Zhang Z; Li Y; Lin Y; Wang G; Zong Y; Liu E
Neurosurg Focus; 2019 Jun; 46(6):E7. PubMed ID: 31153153
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Wilson E; Brandner S; Shieff C; Thorne L
Br J Neurosurg; 2015; 29(5):693-8. PubMed ID: 26098606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
